{"seq": 1, "ts": "2026-02-20T10:25:04.495427+00:00", "agent": "agent1", "cmd": "pm --help", "exit_code": 0, "stdin_lines": 0, "stdout": "pm - PubMed CLI tools for AI agents\n\nUsage: pm <command> [OPTIONS]\n\nCommands:\n  init        Initialize audit trail and cache (.pm/)\n  search      Search PubMed, return PMIDs\n  fetch       Fetch PubMed XML by PMIDs\n  parse       Parse PubMed XML to JSONL\n  filter      Filter JSONL articles by field patterns\n  cite        Fetch CSL-JSON citations\n  download    Download full-text PDFs\n  diff        Compare two JSONL files by PMID\n  audit       View audit trail and PRISMA report\n  quick       One-command search pipeline (outputs JSONL)\n\nExamples:\n  pm search \"CRISPR cancer\" | pm fetch | pm parse > results.jsonl\n  pm quick \"covid vaccine\" --max 50\n  pm filter --year 2024 --has-abstract < articles.jsonl\n\nUse 'pm <command> --help' for command-specific help.\n", "stderr": ""}
{"seq": 2, "ts": "2026-02-20T10:25:11.497829+00:00", "agent": "agent1", "cmd": "pm search --help", "exit_code": 0, "stdin_lines": 0, "stdout": "pm search - Search PubMed and return PMIDs\n\nUsage: pm search [OPTIONS] \"search query\"\n\nOptions:\n  --max N        Maximum results to return (default: 10000)\n  --refresh      Bypass cache and re-fetch from PubMed\n  -h, --help     Show this help message\n\nOutput:\n  PMIDs to stdout, one per line\n\nExamples:\n  pm search \"CRISPR cancer therapy\"\n  pm search --max 100 \"machine learning\"\n  pm search \"covid vaccine 2024\" | pm fetch | pm parse > results.jsonl\n\nQuery syntax:\n  Uses PubMed query syntax. See:\n  https://pubmed.ncbi.nlm.nih.gov/help/#search-tags\n", "stderr": ""}
{"seq": 3, "ts": "2026-02-20T10:25:18.662444+00:00", "agent": "agent1", "cmd": "pm search FES PET imaging lobular breast cancer --max 100", "exit_code": 0, "stdin_lines": 0, "stdout": "41319353\n40976009\n40914389\n40813238\n40761268\n40369385\n40300962\n40067459\n40035673\n39438056\n39385362\n39058489\n38427956\n38365547\n38117098\n38071554\n37239021\n36919879\n36879065\n36243494\n36083216\n35681669\n34545689\n32680923\n32374053\n28604479\n27607175\n25693420\n17515338\n", "stderr": ""}
{"seq": 5, "ts": "2026-02-20T10:25:26.166393+00:00", "agent": "agent1", "cmd": "pm search FES PET imaging lobular breast cancer --max 100", "exit_code": 0, "stdin_lines": 0, "stdout": "41319353\n40976009\n40914389\n40813238\n40761268\n40369385\n40300962\n40067459\n40035673\n39438056\n39385362\n39058489\n38427956\n38365547\n38117098\n38071554\n37239021\n36919879\n36879065\n36243494\n36083216\n35681669\n34545689\n32680923\n32374053\n28604479\n27607175\n25693420\n17515338\n", "stderr": ""}
{"seq": 6, "ts": "2026-02-20T10:25:26.173448+00:00", "agent": "agent1", "cmd": "pm fetch", "exit_code": 0, "stdin_lines": 29, "stdout": "<?xml version=\"1.0\" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2025//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd\">\n<PubmedArticleSet>\n<PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">41319353</PMID><DateCompleted><Year>2026</Year><Month>01</Month><Day>22</Day></DateCompleted><DateRevised><Year>2026</Year><Month>01</Month><Day>22</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1938-0666</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>26</Volume><Issue>1</Issue><PubDate><Year>2026</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Clinical breast cancer</Title><ISOAbbreviation>Clin Breast Cancer</ISOAbbreviation></Journal><ArticleTitle>Staging Invasive Lobular Carcinoma: A Prospective Study on the Efficacy of 18F-Fluoroestradiol (FES)-PET/CT.</ArticleTitle><Pagination><StartPage>36</StartPage><EndPage>46</EndPage><MedlinePgn>36\n... [515459 chars total, truncated] ...\n></MeshHeading><MeshHeading><DescriptorName UI=\"D013274\" MajorTopicYN=\"N\">Stomach Neoplasms</DescriptorName><QualifierName UI=\"Q000000981\" MajorTopicYN=\"Y\">diagnostic imaging</QualifierName><QualifierName UI=\"Q000556\" MajorTopicYN=\"Y\">secondary</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"pubmed\"><Year>2007</Year><Month>5</Month><Day>23</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2007</Year><Month>6</Month><Day>15</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2007</Year><Month>5</Month><Day>23</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">17515338</ArticleId><ArticleId IdType=\"doi\">10.2214/AJR.05.0441</ArticleId><ArticleId IdType=\"pii\">188/6/W503</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>", "stderr": ""}
{"seq": 4, "ts": "2026-02-20T10:25:26.164562+00:00", "agent": "agent1", "cmd": "pm parse", "exit_code": 0, "stdin_lines": 49, "stdout": "{\"pmid\": \"41319353\", \"title\": \"Staging Invasive Lobular Carcinoma: A Prospective Study on the Efficacy of 18F-Fluoroestradiol (FES)-PET/CT.\", \"authors\": [\"Covington Matthew F\", \"Salmon Samantha\", \"Kozlov Andrew\", \"Archibald Zane\", \"Butterfield Regan\", \"Stolk Sophie\", \"Mitchell Sam\", \"Boucher Kenneth\", \"Rosenthal Regina\", \"Porretta Jane\", \"Brownson Kirstyn E\", \"Matsen Cindy\", \"Wei Mei\", \"Buys Saundra\", \"Vaklavas Christos\", \"Chittoria Namita\", \"Buckway Brandon\", \"Meite Angela\", \"Yap Jeffrey\"], \"journal\": \"Clinical breast cancer\", \"year\": \"2026\", \"date\": \"2026-01\", \"abstract\": \"Invasive lobular carcinoma (ILC) often presents diagnostic challenges on conventional imaging, necessitating advanced imaging strategies for accurate staging. [18F]Fluoroestradiol (FES), a PET radiopharmaceutical, targets estrogen receptor-positive (ER+) lesions, which are prevalent in ILC. This study evaluates the utility of FES-PET/CT compared to standard-of-care (SOC) imaging for staging ER+ ILC. This IRB-approv\n... [71198 chars total, truncated] ...\nr large number of alternative tracers that are in development or even routinely available in some countries, few FDHT studies have been published until now. From absorbed dose values previously published for FES by the team of University of Washington School of Medicine at Seattle, and for FDHT by the teams of Memorial Sloan-Kettering Cancer Center at New York and of Washington University at St. Louis, we applied the coefficients of ICRP publication 103 and calculated an effective dose per unit of injected activity of 0.023 mSv/MBq for FES and 0.018 mSv/MBq for FDHT. The radiation exposure is of the same order of magnitude as with FDG.\"}\n{\"pmid\": \"17515338\", \"title\": \"Gastric linitis plastica from metastatic breast carcinoma: FDG and FES PET appearances.\", \"authors\": [\"Kanne Jeffrey P\", \"Mankoff David A\", \"Baird Geoffrey S\", \"Minoshima Satoshi\", \"Livingston Robert B\"], \"journal\": \"AJR. American journal of roentgenology\", \"year\": \"2007\", \"date\": \"2007-06\", \"doi\": \"10.2214/AJR.05.0441\"}\n", "stderr": ""}
{"seq": 7, "ts": "2026-02-20T10:25:43.601092+00:00", "agent": "agent1", "cmd": "pm filter --year 2024 --has-abstract", "exit_code": 0, "stdin_lines": 29, "stdout": "{\"pmid\": \"39438056\", \"title\": \"A Rare Case of Orbital Metastasis from Invasive Lobular Carcinoma: Challenges of 18F-FDG PET/CT and the Search for Consensus on Imaging.\", \"authors\": [\"Lam Marjorie\", \"Yang Johnny\", \"Vijayakumar Vani\"], \"journal\": \"Journal of nuclear medicine technology\", \"year\": \"2024\", \"date\": \"2024-12-04\", \"abstract\": \"Invasive lobular carcinoma (ILC) frequently underlies orbital metastasis. A 74-y-old woman, who was current with mammograms and had no cancer history, presented to her ophthalmologist with visual complaints and was found to have metastatic ILC. MRI was contraindicated, and an 18F-FDG PET/CT scan revealed a mildly hypermetabolic right orbital mass and low uptake in the left subareolar breast, suggestive of metastatic ILC. Small studies have found that in ILC, 16\u03b1-18F-fluoroestradiol and fibroblast activation protein inhibitors are more avid than 18F-FDG. There is currently no consensus regarding imaging for ILC. Many people have contraindications to MRI, \n... [18325 chars total, truncated] ...\nng the results of [18F]FES PET studies for patients with breast cancer and to provide clinicians with the best available evidence, inform them about areas where robust evidence is lacking, and help them deliver the best possible diagnostic efficacy and study quality for their patients. Also reviewed are standardized quality control, quality assurance, and imaging procedures for [18F]FES PET. The authors emphasize the importance of precision, accuracy, repeatability, and reproducibility for both clinical management of patients and for use of [18F]FES PET in multicenter trials. A standardized imaging procedure, in combination with already published appropriate-use criteria, will help promote the use of [18F]FES PET and enhance subsequent research. This brief summary article reviews the content of the joint standard/guideline, which is available in its entirety at https://www.snmmi.org/ClinicalPractice/content.aspx?ItemNumber=6414&navItemNumbe=10790.\", \"doi\": \"10.2967/jnumed.123.266938\"}\n", "stderr": ""}
{"seq": 8, "ts": "2026-02-20T10:27:10.042685+00:00", "agent": "agent1", "cmd": "pm --help", "exit_code": 0, "stdin_lines": 0, "stdout": "pm - PubMed CLI tools for AI agents\n\nUsage: pm <command> [OPTIONS]\n\nCommands:\n  init        Initialize audit trail and cache (.pm/)\n  search      Search PubMed, return PMIDs\n  fetch       Fetch PubMed XML by PMIDs\n  parse       Parse PubMed XML to JSONL\n  filter      Filter JSONL articles by field patterns\n  cite        Fetch CSL-JSON citations\n  download    Download full-text PDFs\n  diff        Compare two JSONL files by PMID\n  audit       View audit trail and PRISMA report\n  quick       One-command search pipeline (outputs JSONL)\n\nExamples:\n  pm search \"CRISPR cancer\" | pm fetch | pm parse > results.jsonl\n  pm quick \"covid vaccine\" --max 50\n  pm filter --year 2024 --has-abstract < articles.jsonl\n\nUse 'pm <command> --help' for command-specific help.\n", "stderr": ""}
{"seq": 9, "ts": "2026-02-20T10:27:18.150415+00:00", "agent": "agent1", "cmd": "pm search --help", "exit_code": 0, "stdin_lines": 0, "stdout": "pm search - Search PubMed and return PMIDs\n\nUsage: pm search [OPTIONS] \"search query\"\n\nOptions:\n  --max N        Maximum results to return (default: 10000)\n  --refresh      Bypass cache and re-fetch from PubMed\n  -h, --help     Show this help message\n\nOutput:\n  PMIDs to stdout, one per line\n\nExamples:\n  pm search \"CRISPR cancer therapy\"\n  pm search --max 100 \"machine learning\"\n  pm search \"covid vaccine 2024\" | pm fetch | pm parse > results.jsonl\n\nQuery syntax:\n  Uses PubMed query syntax. See:\n  https://pubmed.ncbi.nlm.nih.gov/help/#search-tags\n", "stderr": ""}
{"seq": 10, "ts": "2026-02-20T10:27:25.064885+00:00", "agent": "agent1", "cmd": "pm search FES PET imaging lobular breast cancer --max 100", "exit_code": 0, "stdin_lines": 0, "stdout": "41319353\n40976009\n40914389\n40813238\n40761268\n40369385\n40300962\n40067459\n40035673\n39438056\n39385362\n39058489\n38427956\n38365547\n38117098\n38071554\n37239021\n36919879\n36879065\n36243494\n36083216\n35681669\n34545689\n32680923\n32374053\n28604479\n27607175\n25693420\n17515338\n", "stderr": ""}
{"seq": 11, "ts": "2026-02-20T10:27:32.605191+00:00", "agent": "agent1", "cmd": "pm fetch --help", "exit_code": 0, "stdin_lines": 0, "stdout": "pm fetch - Fetch PubMed XML from E-utilities API\n\nUsage: echo \"12345\" | pm fetch > articles.xml\n       cat pmids.txt | pm fetch > articles.xml\n\nOptions:\n  -v, --verbose  Show progress on stderr\n  -h, --help     Show this help message\n\nInput:\n  PMIDs from stdin, one per line\n\nOutput:\n  PubMed XML to stdout\n\nFeatures:\n  - Batches requests (200 PMIDs per API call)\n  - Rate limits to ~3 requests/second\n  - Exits with error on network failure\n\nExamples:\n  echo \"12345\" | pm fetch > article.xml\n  cat pmids.txt | pm fetch > articles.xml\n  pm search \"CRISPR\" | pm fetch | pm parse > results.jsonl\n", "stderr": ""}
{"seq": 12, "ts": "2026-02-20T10:27:39.489977+00:00", "agent": "agent1", "cmd": "pm parse --help", "exit_code": 0, "stdin_lines": 0, "stdout": "pm parse - Parse PubMed XML to JSONL\n\nUsage: cat articles.xml | pm parse [OPTIONS] > articles.jsonl\n       zcat articles.xml.gz | pm parse [OPTIONS] > articles.jsonl\n\nOptions:\n  -v, --verbose  Show progress on stderr\n  -h, --help     Show this help message\n\nOutput:\n  One JSON object per line (JSONL format) with fields:\n    pmid, title, authors, journal, year, date, doi, pmcid, abstract\n\nExamples:\n  cat pubmed.xml | pm parse > articles.jsonl\n  zcat pubmed25n0001.xml.gz | pm parse > articles.jsonl\n  cat pubmed.xml | pm parse --verbose > articles.jsonl 2>progress.log\n", "stderr": ""}
{"seq": 14, "ts": "2026-02-20T10:27:46.144547+00:00", "agent": "agent1", "cmd": "pm search FES PET imaging lobular breast cancer --max 100", "exit_code": 0, "stdin_lines": 0, "stdout": "41319353\n40976009\n40914389\n40813238\n40761268\n40369385\n40300962\n40067459\n40035673\n39438056\n39385362\n39058489\n38427956\n38365547\n38117098\n38071554\n37239021\n36919879\n36879065\n36243494\n36083216\n35681669\n34545689\n32680923\n32374053\n28604479\n27607175\n25693420\n17515338\n", "stderr": ""}
{"seq": 15, "ts": "2026-02-20T10:27:55.540284+00:00", "agent": "agent1", "cmd": "pm init", "exit_code": 0, "stdin_lines": 0, "stdout": "Initialized .pm/ in /home/user/pm-tools/e2e/workdirs/agent1\nAudit trail: .pm/audit.jsonl\nCache: .pm/cache/\n", "stderr": ""}
{"seq": 17, "ts": "2026-02-20T10:28:02.443622+00:00", "agent": "agent1", "cmd": "pm search FES PET imaging lobular breast cancer --max 100", "exit_code": 0, "stdin_lines": 0, "stdout": "41319353\n40976009\n40914389\n40813238\n40761268\n40369385\n40300962\n40067459\n40035673\n39438056\n39385362\n39058489\n38427956\n38365547\n38117098\n38071554\n37239021\n36919879\n36879065\n36243494\n36083216\n35681669\n34545689\n32680923\n32374053\n28604479\n27607175\n25693420\n17515338\n", "stderr": ""}
{"seq": 16, "ts": "2026-02-20T10:28:02.438607+00:00", "agent": "agent1", "cmd": "pm fetch", "exit_code": 0, "stdin_lines": 29, "stdout": "<?xml version=\"1.0\" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2024//EN\"\n \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd\">\n<PubmedArticleSet>\n<PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">41319353</PMID><DateCompleted><Year>2026</Year><Month>01</Month><Day>22</Day></DateCompleted><DateRevised><Year>2026</Year><Month>01</Month><Day>22</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1938-0666</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>26</Volume><Issue>1</Issue><PubDate><Year>2026</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Clinical breast cancer</Title><ISOAbbreviation>Clin Breast Cancer</ISOAbbreviation></Journal><ArticleTitle>Staging Invasive Lobular Carcinoma: A Prospective Study on the Efficacy of 18F-Fluoroestradiol (FES)-PET/CT.</ArticleTitle><Pagination><StartPage>36</StartPage><EndPage>46</EndPage><MedlinePgn>3\n... [509523 chars total, truncated] ...\n</MeshHeading><MeshHeading><DescriptorName UI=\"D013274\" MajorTopicYN=\"N\">Stomach Neoplasms</DescriptorName><QualifierName UI=\"Q000000981\" MajorTopicYN=\"Y\">diagnostic imaging</QualifierName><QualifierName UI=\"Q000556\" MajorTopicYN=\"Y\">secondary</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"pubmed\"><Year>2007</Year><Month>5</Month><Day>23</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2007</Year><Month>6</Month><Day>15</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2007</Year><Month>5</Month><Day>23</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">17515338</ArticleId><ArticleId IdType=\"doi\">10.2214/AJR.05.0441</ArticleId><ArticleId IdType=\"pii\">188/6/W503</ArticleId></ArticleIdList></PubmedData></PubmedArticle>\n</PubmedArticleSet>", "stderr": ""}
{"seq": 18, "ts": "2026-02-20T10:28:02.446006+00:00", "agent": "agent1", "cmd": "pm parse", "exit_code": 0, "stdin_lines": 79, "stdout": "{\"pmid\": \"41319353\", \"title\": \"Staging Invasive Lobular Carcinoma: A Prospective Study on the Efficacy of 18F-Fluoroestradiol (FES)-PET/CT.\", \"authors\": [\"Covington Matthew F\", \"Salmon Samantha\", \"Kozlov Andrew\", \"Archibald Zane\", \"Butterfield Regan\", \"Stolk Sophie\", \"Mitchell Sam\", \"Boucher Kenneth\", \"Rosenthal Regina\", \"Porretta Jane\", \"Brownson Kirstyn E\", \"Matsen Cindy\", \"Wei Mei\", \"Buys Saundra\", \"Vaklavas Christos\", \"Chittoria Namita\", \"Buckway Brandon\", \"Meite Angela\", \"Yap Jeffrey\"], \"journal\": \"Clinical breast cancer\", \"year\": \"2026\", \"date\": \"2026-01\", \"abstract\": \"Invasive lobular carcinoma (ILC) often presents diagnostic challenges on conventional imaging, necessitating advanced imaging strategies for accurate staging. [18F]Fluoroestradiol (FES), a PET radiopharmaceutical, targets estrogen receptor-positive (ER+) lesions, which are prevalent in ILC. This study evaluates the utility of FES-PET/CT compared to standard-of-care (SOC) imaging for staging ER+ ILC. This IRB-approv\n... [71198 chars total, truncated] ...\nr large number of alternative tracers that are in development or even routinely available in some countries, few FDHT studies have been published until now. From absorbed dose values previously published for FES by the team of University of Washington School of Medicine at Seattle, and for FDHT by the teams of Memorial Sloan-Kettering Cancer Center at New York and of Washington University at St. Louis, we applied the coefficients of ICRP publication 103 and calculated an effective dose per unit of injected activity of 0.023 mSv/MBq for FES and 0.018 mSv/MBq for FDHT. The radiation exposure is of the same order of magnitude as with FDG.\"}\n{\"pmid\": \"17515338\", \"title\": \"Gastric linitis plastica from metastatic breast carcinoma: FDG and FES PET appearances.\", \"authors\": [\"Kanne Jeffrey P\", \"Mankoff David A\", \"Baird Geoffrey S\", \"Minoshima Satoshi\", \"Livingston Robert B\"], \"journal\": \"AJR. American journal of roentgenology\", \"year\": \"2007\", \"date\": \"2007-06\", \"doi\": \"10.2214/AJR.05.0441\"}\n", "stderr": ""}
{"seq": 19, "ts": "2026-02-20T10:28:19.176590+00:00", "agent": "agent1", "cmd": "pm filter --help", "exit_code": 0, "stdin_lines": 0, "stdout": "pm filter - Filter JSONL articles by field patterns\n\nUsage: pm parse | pm filter [OPTIONS]\n       cat articles.jsonl | pm filter [OPTIONS]\n\nFilter Options:\n  --year PATTERN      Year filter (exact, range, or open-ended)\n                      Examples: 2024, 2020-2024, 2020-, -2024\n  --journal PATTERN   Journal contains PATTERN (case-insensitive)\n  --journal-exact STR Journal equals STR exactly\n  --author PATTERN    Any author contains PATTERN (case-insensitive)\n  --has-abstract      Article has non-empty abstract\n  --has-doi           Article has DOI\n\nGeneral Options:\n  -v, --verbose       Show filter stats on stderr\n  -h, --help          Show this help\n\nExamples:\n  pm filter --year 2020- --journal nature --has-abstract\n  pm filter --author smith\n  pm filter --year 2020-2024\n\nNotes:\n  - Multiple filters combine with AND logic\n  - Malformed JSON lines are silently skipped\n", "stderr": ""}
{"seq": 20, "ts": "2026-02-20T10:28:28.681926+00:00", "agent": "agent1", "cmd": "pm filter --year 2020- --has-abstract --has-doi -v", "exit_code": 0, "stdin_lines": 29, "stdout": "{\"pmid\": \"41319353\", \"title\": \"Staging Invasive Lobular Carcinoma: A Prospective Study on the Efficacy of 18F-Fluoroestradiol (FES)-PET/CT.\", \"authors\": [\"Covington Matthew F\", \"Salmon Samantha\", \"Kozlov Andrew\", \"Archibald Zane\", \"Butterfield Regan\", \"Stolk Sophie\", \"Mitchell Sam\", \"Boucher Kenneth\", \"Rosenthal Regina\", \"Porretta Jane\", \"Brownson Kirstyn E\", \"Matsen Cindy\", \"Wei Mei\", \"Buys Saundra\", \"Vaklavas Christos\", \"Chittoria Namita\", \"Buckway Brandon\", \"Meite Angela\", \"Yap Jeffrey\"], \"journal\": \"Clinical breast cancer\", \"year\": \"2026\", \"date\": \"2026-01\", \"abstract\": \"Invasive lobular carcinoma (ILC) often presents diagnostic challenges on conventional imaging, necessitating advanced imaging strategies for accurate staging. [18F]Fluoroestradiol (FES), a PET radiopharmaceutical, targets estrogen receptor-positive (ER+) lesions, which are prevalent in ILC. This study evaluates the utility of FES-PET/CT compared to standard-of-care (SOC) imaging for staging ER+ ILC. This IRB-approv\n... [64477 chars total, truncated] ...\n18 F-FES PET scans. This imaging assay has potential to improve clinically relevant outcomes for patients with (historically) ER-positive metastatic breast cancer, including those with brain metastases and/or lobular histology. IMPLICATIONS FOR PRACTICE: 16\u03b1-18F-fluoro-17\u03b2-estradiol positron emission tomography (18 F-FES PET) imaging assesses estrogen receptor status in breast cancer in vivo. This work reviews the sensitivity and specificity of 18 F-FES PET in a meta-analysis with reference tissue assays and discusses best practices for use of the tracer as an imaging biomarker. 18 F-FES PET could enhance breast cancer diagnosis and staging as well as aid in therapy selection for patients with metastatic disease. Tissue sampling limitations, intrapatient heterogeneity, and temporal changes in molecular markers make it likely that 18 F-FES PET will complement existing assays when clinically available in the near future.\", \"pmcid\": \"PMC7543360\", \"doi\": \"10.1634/theoncologist.2019-0967\"}\n", "stderr": "25 articles passed filters\n"}
{"seq": 21, "ts": "2026-02-20T10:28:37.199240+00:00", "agent": "agent1", "cmd": "pm filter --year 2020- --has-abstract --has-doi", "exit_code": 0, "stdin_lines": 29, "stdout": "{\"pmid\": \"41319353\", \"title\": \"Staging Invasive Lobular Carcinoma: A Prospective Study on the Efficacy of 18F-Fluoroestradiol (FES)-PET/CT.\", \"authors\": [\"Covington Matthew F\", \"Salmon Samantha\", \"Kozlov Andrew\", \"Archibald Zane\", \"Butterfield Regan\", \"Stolk Sophie\", \"Mitchell Sam\", \"Boucher Kenneth\", \"Rosenthal Regina\", \"Porretta Jane\", \"Brownson Kirstyn E\", \"Matsen Cindy\", \"Wei Mei\", \"Buys Saundra\", \"Vaklavas Christos\", \"Chittoria Namita\", \"Buckway Brandon\", \"Meite Angela\", \"Yap Jeffrey\"], \"journal\": \"Clinical breast cancer\", \"year\": \"2026\", \"date\": \"2026-01\", \"abstract\": \"Invasive lobular carcinoma (ILC) often presents diagnostic challenges on conventional imaging, necessitating advanced imaging strategies for accurate staging. [18F]Fluoroestradiol (FES), a PET radiopharmaceutical, targets estrogen receptor-positive (ER+) lesions, which are prevalent in ILC. This study evaluates the utility of FES-PET/CT compared to standard-of-care (SOC) imaging for staging ER+ ILC. This IRB-approv\n... [64477 chars total, truncated] ...\n18 F-FES PET scans. This imaging assay has potential to improve clinically relevant outcomes for patients with (historically) ER-positive metastatic breast cancer, including those with brain metastases and/or lobular histology. IMPLICATIONS FOR PRACTICE: 16\u03b1-18F-fluoro-17\u03b2-estradiol positron emission tomography (18 F-FES PET) imaging assesses estrogen receptor status in breast cancer in vivo. This work reviews the sensitivity and specificity of 18 F-FES PET in a meta-analysis with reference tissue assays and discusses best practices for use of the tracer as an imaging biomarker. 18 F-FES PET could enhance breast cancer diagnosis and staging as well as aid in therapy selection for patients with metastatic disease. Tissue sampling limitations, intrapatient heterogeneity, and temporal changes in molecular markers make it likely that 18 F-FES PET will complement existing assays when clinically available in the near future.\", \"pmcid\": \"PMC7543360\", \"doi\": \"10.1634/theoncologist.2019-0967\"}\n", "stderr": ""}
{"seq": 22, "ts": "2026-02-20T10:29:25.253189+00:00", "agent": "agent1", "cmd": "pm audit", "exit_code": 0, "stdin_lines": 0, "stdout": "Audit Trail Summary\n===================\n\nTotal operations: 5\n\n  fetch            1\n  filter           2\n  init             1\n  search           1\n", "stderr": ""}
{"seq": 23, "ts": "2026-02-20T10:29:32.610555+00:00", "agent": "agent1", "cmd": "pm cite --help", "exit_code": 0, "stdin_lines": 0, "stdout": "pm cite - Fetch CSL-JSON citations from NCBI Citation Exporter API\n\nUsage: echo \"12345\" | pm cite > citations.jsonl\n       pm cite 12345 67890 > citations.jsonl\n\nOptions:\n  -v, --verbose  Show progress on stderr\n  -h, --help     Show this help message\n\nOutput:\n  JSONL format (one CSL-JSON object per line)\n", "stderr": ""}
{"seq": 24, "ts": "2026-02-20T10:29:42.076359+00:00", "agent": "agent1", "cmd": "pm cite", "exit_code": 0, "stdin_lines": 5, "stdout": "{\"source\": \"PubMed\", \"accessed\": {\"date-parts\": [[2026, 2, 20]]}, \"id\": \"pmid:41319353\", \"title\": \"Staging Invasive Lobular Carcinoma: A Prospective Study on the Efficacy of 18F-Fluoroestradiol (FES)-PET/CT\", \"author\": [{\"family\": \"Covington\", \"given\": \"Matthew F\"}, {\"family\": \"Salmon\", \"given\": \"Samantha\"}, {\"family\": \"Kozlov\", \"given\": \"Andrew\"}, {\"family\": \"Archibald\", \"given\": \"Zane\"}, {\"family\": \"Butterfield\", \"given\": \"Regan\"}, {\"family\": \"Stolk\", \"given\": \"Sophie\"}, {\"family\": \"Mitchell\", \"given\": \"Sam\"}, {\"family\": \"Boucher\", \"given\": \"Kenneth\"}, {\"family\": \"Rosenthal\", \"given\": \"Regina\"}, {\"family\": \"Porretta\", \"given\": \"Jane\"}, {\"family\": \"Brownson\", \"given\": \"Kirstyn E\"}, {\"family\": \"Matsen\", \"given\": \"Cindy\"}, {\"family\": \"Wei\", \"given\": \"Mei\"}, {\"family\": \"Buys\", \"given\": \"Saundra\"}, {\"family\": \"Vaklavas\", \"given\": \"Christos\"}, {\"family\": \"Chittoria\", \"given\": \"Namita\"}, {\"family\": \"Buckway\", \"given\": \"Brandon\"}, {\"family\": \"Meite\", \"given\": \"Angela\"}, {\"family\": \"Yap\", \"gi\n... [5485 chars total, truncated] ...\nsher-place\": \"United States\", \"ISSN\": \"0161-5505\", \"issued\": {\"date-parts\": [[2025, 10, 1]]}, \"page\": \"1555-1560\", \"volume\": \"66\", \"issue\": \"10\", \"PMID\": \"40813238\", \"DOI\": \"10.2967/jnumed.125.269573\", \"type\": \"article-journal\"}\n{\"source\": \"PubMed\", \"accessed\": {\"date-parts\": [[2026, 2, 20]]}, \"id\": \"pmid:40761268\", \"title\": \"A case of invasive lobular carcinoma, highlighting the emerging role of <sup>18</sup>F-Fluoroestradiol PET\", \"author\": [{\"family\": \"Wallace\", \"given\": \"Michael\"}, {\"family\": \"Tavana\", \"given\": \"Anahita\"}, {\"family\": \"Leon\", \"given\": \"Amie\"}, {\"family\": \"Maimone\", \"given\": \"Santo\"}, {\"family\": \"Letter\", \"given\": \"Haley\"}], \"container-title-short\": \"Radiol Case Rep\", \"container-title\": \"Radiology case reports\", \"publisher-place\": \"Netherlands\", \"ISSN\": \"1930-0433\", \"issued\": {\"date-parts\": [[2025, 7, 28]]}, \"page\": \"5172-5177\", \"volume\": \"20\", \"issue\": \"10\", \"PMID\": \"40761268\", \"PMCID\": \"PMC12320061\", \"DOI\": \"10.1016/j.radcr.2025.06.105\", \"type\": \"article-journal\"}\n", "stderr": ""}
